Investing personality Jim Cramer recently called Recursion Pharmaceuticals a meme stock. The facts don't back up that position, though. Recursion may not be a meme stock, but that doesn't make it a ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Trump administration officials are weighing a controversial maneuver aimed at allowing them to block federal funding previously authorized by Congress without lawmakers’ approval. White House budget ...

GM has announced it is adding another plant to support production of its sixth generation V-8 for use in full-size trucks and SUVs. And it's putting up big-time money on the project. Original story ...

Recursion said it will end development for four of its 11 pipeline programs—one of which the company will consider outlicensing to a partner instead—and pause a fifth program, in a pruning designed to ...

Google has made a change to how it’s search results are served which will also help to secure it against bots and scrapers. Whether this will have further effect on SEO Tools or if they can use a ...

Recursion Pharmaceuticals (RXRX) closed at $6.36 in the latest trading session, marking a +0.47% move from the prior day. This change outpaced the S&P 500's 0.22% gain on the day. Meanwhile, the Dow ...

Qualcomm is scheduled to launch its next-gen Snapdragon 8 Gen 4 processor later this month. But before the official unveiling, a leak just spoiled the surprise with a detailed look at the processor’s ...

The satellite internet service controlled by Elon Musk is refusing to comply with a court order to block his social network, X, regulators said. By Jack Nicas Reporting from Rio de Janeiro Elon Musk ...